NEW YORK, November 7, 2024 – Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and ...
Living with type 1 diabetes? Get essential tips, relatable insights, and support tailored for Singaporean parents! Here's to living fully and thriving! #Type1Diabetes ...